loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Locapred

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Locapred

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,455Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alembic gets USFDA nod for generic skin treatment cream
    Alembic gets USFDA nod for generic skin treatment cream

    09 Dec 2022

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-gets-usfda-nod-for-generic-skin-treatment-cream/articleshow/96103966.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    09 Dec 2022
    Share Share
    Aleor's Generic Desonide Receives Approval in the U.S.
    Aleor's Generic Desonide Receives Approval in the U.S.

    08 Dec 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214396

    FDA
    08 Dec 2022
    Share Share
    Aleor Dermaceuticals Generic Desonide Receives Approval in US
    Aleor Dermaceuticals Generic Desonide Receives Approval in US

    27 Aug 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213632

    FDA
    27 Aug 2020
    Share Share
    Teresina `s Generic Desonide Receives Approval in US
    Teresina `s Generic Desonide Receives Approval in US

    15 May 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202470

    FDA
    15 May 2020
    Share Share
    Cadila Healthcare's Generic Desonide Receives Approval in US
    Cadila Healthcare's Generic Desonide Receives Approval in US

    21 Nov 2019

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210060

    FDA
    21 Nov 2019
    Share Share
    Aleor Dermaceuticals Generic Desonide Receives Approval in US
    Aleor Dermaceuticals Generic Desonide Receives Approval in US

    25 Oct 2019

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212473

    FDA
    25 Oct 2019
    Share Share